Current status of PET/CT in the diagnosis and follow up of lymphomas
Current status of PET/CT in the diagnosis and follow up of lymphomas
复制标题
DOI：
10.5581/1516-8484.20110035
复制
发表时间：
2011-01-01
影响因子：
--
通讯作者：
Buchpiguel, Carlos Alberto
中科院分区：
文献类型：
--
作者：
Buchpiguel, Carlos Alberto
淋巴瘤是一组不同的恶性肿瘤，根据其亚型和分化程度有不同的生物学行为。充分的分期对预后有直接影响，对于恰当的治疗计划是至关重要的。结构横断面成像，如计算机断层扫描，已经成为诊断和监测淋巴瘤患者的标准成像工具。然而，分子成像，如正电子发射断层扫描，已显示出互补的诊断和预后价值。本文讨论了2-[氟-18]氟-2-脱氧-d-葡萄糖正电子发射断层扫描在霍奇金淋巴瘤和非霍奇金淋巴瘤分期、再分期、监测和检测复发中的价值。
Lymphomas are a heterogeneous group of malignancies that have a distinct biological behavior according to the subtype and degree of differentiation. Adequate staging, which has a direct impact on prognosis, is essential to properly plan therapy. Structural cross-sectional imaging, such as computed tomography, has been the standard imaging tool to stage and monitor patients with lymphoma. However, molecular imaging such as positron emission tomography has shown complementary diagnostic and prognostic values. This review discusses the current value of positron emission tomography imaging using 2-[fluorine-18]fluoro-2-deoxy-d-glucose in staging, restaging, monitoring and detecting relapse in Hodgkin's and non-Hodgkin lymphoma.